Thyroid stunning in radioiodine-131 therapy of benign thyroid diseases

C Happel, WT Kranert, H Ackermann, I Binse… - Endocrine, 2019 - Springer
Purpose Existence and cause of thyroid stunning was controversially discussed for decades
but the underlying mechanism remains unclear. Numerous studies describe thyroid stunning …

Correction for hyperfunctioning radiation-induced stunning (CHRIS) in benign thyroid diseases

C Happel, WT Kranert, D Gröner, B Bockisch, A Sabet… - Endocrine, 2020 - Springer
Purpose Radioiodine-131 treatment has been a well-established therapy for benign thyroid
diseases for more than 75 years. However, the physiological reasons of the so-called …

Thyroid stunning

LF Morris, AD Waxman, GD Braunstein - Thyroid, 2003 - liebertpub.com
Debates regarding thyroid stunning—a phenomenon whereby a diagnostic dose of
radioiodine decreases uptake of a subsequent therapeutic dose by remnant thyroid tissue or …

Stunning in radioiodine therapy of benign thyroid disease

T Krohn, PT Meyer, C Ocklenburg… - Nuklearmedizin …, 2008 - thieme-connect.com
In radioiodine therapy of benign thyroid disease, a reduction of radioiodine uptake is known
for consecutive administrations of 131 I, which needs to be considered in therapy planning …

Does thyroid stunning exist? A model with benign thyroid disease

O Sabri, M Zimny, M Schreckenberger… - European journal of …, 2000 - Springer
With regard to the treatment of differentiated non-medullary thyroid carcinoma, there is
controversy over whether radiation from a diagnostic radioiodine (131 I) application really …

Stunning: Untoward Effect of 131I Thyroid Imaging Prior to Radioablation Therapy

HM Park, SK Gerard - Thyroid cancer: A comprehensive guide to clinical …, 2006 - Springer
Thyroid stunning is a radiobiological phenomenon. It may be defined as a temporary
suppression of iodine, trapping function of the thyrocytes and thyroid cancer cells as a result …

[HTML][HTML] Radioiodine Treatment for Benign Thyroid Diseases

A Akbulut, FN Aydinbelge, G Koca - Radionuclide Treatments, 2017 - intechopen.com
Radioiodine (RAI) is becoming the preferred treating option for benign thyroid diseases.
Hyperthyroidism is defined as hypermetabolic state caused by high levels of circulating …

Thyroid stunning in vivo and in vitro

M Medvedec - Nuclear medicine communications, 2005 - journals.lww.com
Aim To review published in-vivo and in-vitro quantitative dosimetric studies on thyroid
stunning in order to derive novel data applicable in clinical practice. Methods A non-linear …

The influence of thyroid hormone medication on intra-therapeutic half-life of 131I during radioiodine therapy of solitary toxic thyroid nodules

C Happel, WT Kranert, B Bockisch, A Sabet… - Scientific Reports, 2022 - nature.com
Despite a significantly improved dietary iodine supply, solitary toxic thyroid nodules (STN)
are still a common clinical problem in former iodine deficient areas. Radioiodine treatment …

[HTML][HTML] Is thyroid stunning clinically relevant? A retrospective analysis of 208 patients

ECSC Etchebehere, AO Santos, PS Matos… - … de Endocrinologia & …, 2014 - SciELO Brasil
Objective: Current guidelines have advised against the performance of 131I-iodide
diagnostic whole body scintigraphy (dxWBS) to minimize the occurrence of stunning, and to …